Next-generation Ultrasound System, the SONIMAGE HS2, Delivers Advanced Features for Precision Diagnosis and Interventions

SONIMAGE HS2 Compact Ultrasound System

The new SONIMAGE® HS2 Compact Ultrasound System from Konica Minolta Healthcare.

WAYNE, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) — Konica Minolta Healthcare Americas, Inc. introduces the next-generation, compact ultrasound system, SONIMAGE® HS2, featuring advanced image clarity and innovative functionality optimized for point-of-care environments. Building on the company’s advanced ultrasound technology, the HS2 System delivers superior image quality and simplified operation to help clinicians address an array of clinical applications in musculoskeletal, vascular, pain management, interventional and orthobiologics.

“Ultrasound is an invaluable bedside tool that delivers a dynamic evaluation of the anatomy, benefitting the patient and the provider,” says Joan Toth, Senior Product Marketing Manager, Konica Minolta Healthcare. “With the SONIMAGE HS2, clinicians have real-time information to make better decisions sooner, streamline care and enhance patient satisfaction. Clinicians can keep more procedures in-house and expand their services to include more complex interventions safely and efficiently. The SONIMAGE HS2 was designed for ease of use, enabling providers to do more at the point of care quickly and confidently.”

The new SONIMAGE HS2 provides enhanced needle guidance, superior image quality, high-resolution blood flow imaging and an intuitive, wide view touchscreen monitor. Konica Minolta’s Dual Sonic technology utilizes a unique algorithm that transmits two waveforms depending on the focal length, providing the clarity and high signal needed for deep tissue imaging. Improved Tissue Harmonics technology suppresses acoustic noise and increases both frequency and sensitivity for deep tissue and superficial imaging. When coupled with the company’s wide bandwidth L18-4 probe, users achieve exceptional image quality with improved fine details and contrast resolution for precision in diagnostic and interventional procedures.

Additional enhancements include higher resolution and faster frame rates, enabling more clear visualization of small vessels and slow blood flow. Simple Needle Visualization, or SNV®, software is optimized for confident needle guidance.

Simplifying operation is Konica Minolta’s touchscreen display that now includes the ability to annotate and draw lines, notes or figures with a finger and save them for documentation and reporting. Pre-set focused exams minimize the learning curve and facilitate ease-of-use. The touchscreen display can be configured to full screen for ease of viewing, especially during interventions.

Konica Minolta Healthcare is introducing the SONIMAGE HS2 at the virtual annual meeting of the Radiological Society of North America (RSNA), being held November 29 to December 5.

About Konica Minolta Healthcare Americas, Inc.
Konica Minolta Healthcare is a world-class provider and market leader in medical diagnostic imaging and healthcare information technology. With over 75 years of endless innovation, Konica Minolta is globally recognized as a leader providing cutting-edge technologies and comprehensive support aimed at providing real solutions to meet customer’s needs and helping make better decisions sooner. Konica Minolta Healthcare Americas, Inc., headquartered in Wayne, NJ, is a unit of Konica Minolta, Inc. (TSE:4902). For more information on Konica Minolta Healthcare Americas, Inc., please visit www.konicaminolta.com/medicalusa.

Contact: 
Mary Beth Massat 
Massat Media
224.578.2388
www.konicaminolta.com/medicalusa

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/b5fe1fd6-7045-4213-92d0-5cebb238b6cd

Staff

Recent Posts

BioHarvest Launches VINIA SuperFood Functional Tea Line

Incremental Product Launch Addresses $3.3 Billion North American Functional Tea Market Opportunity with First SuperFood…

23 minutes ago

Neurotech Innovator UNEEG Medical Receives FDA Breakthrough Device Designation Within Monitoring and Diagnostic of Epilepsy

The designation is a result of UNEEG's strong focus on developing novel disease management support…

23 minutes ago

Lexaria’s GLP-1 Human Pilot Study #3 Completes Dosing as Scheduled

DehydraTECH-processed tirzepatide from Zepbound® is being tested in an oral dose format KELOWNA, BC /…

24 minutes ago

S4 Medical Receives FDA 510(k) Approval for its Redesigned Esophageal Deviation Device and Begins Commercialization

CHAGRIN FALLS, OH / ACCESSWIRE / November 25, 2024 / S4 Medical Corp, an Ohio…

24 minutes ago

Acreage Provides Update on Corporate Transactions

NEW YORK, NY / ACCESSWIRE / November 25, 2024 / Acreage Holdings, Inc. ("Acreage" or…

24 minutes ago